about
Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriensThe Snake with the Scorpion's Sting: Novel Three-Finger Toxin Sodium Channel Activators from the Venom of the Long-Glanded Blue Coral Snake (Calliophis bivirgatus)Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a.Multiple sodium channel isoforms mediate the pathological effects of Pacific ciguatoxin-1.The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variant.An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathwaysΔ-Myrtoxin-Mp1a is a Helical Heterodimer from the Venom of the Jack Jumper Ant that has Antimicrobial, Membrane-Disrupting, and Nociceptive Activities.α-Conotoxin MrIC is a biased agonist at α7 nicotinic acetylcholine receptors.NaV1.7 as a pain target - From gene to pharmacology.Analgesic treatment of ciguatoxin-induced cold allodynia.The pharmacology of voltage-gated sodium channel activators.Sodium Channels and Venom Peptide Pharmacology.Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain.Role of the NLRP3 inflammasome in a model of acute burn-induced pain.Transcriptomic and behavioural characterisation of a mouse model of burn pain identify the cholecystokinin 2 receptor as an analgesic target.Methods Used to Evaluate Pain Behaviors in Rodents.Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi.Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin.The thermal probe test: A novel behavioral assay to quantify thermal paw withdrawal thresholds in mice.Activation of κ Opioid Receptors in Cutaneous Nerve Endings by Conorphin-1, a Novel Subtype-Selective Conopeptide, Does Not Mediate Peripheral Analgesia.Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species.Role of complement anaphylatoxin receptors in a mouse model of acute burn-induced pain.Burn Pain: A Systematic and Critical Review of Epidemiology, Pathophysiology, and Treatment.Modulatory features of the novel spider toxin μ-TRTX-Df1a isolated from the venom of the spider Davus fasciatus.The E15R Point Mutation in Scorpion Toxin Cn2 Uncouples Its Depressant and Excitatory Activities on Human NaV1.6.Toxins as tools: Fingerprinting neuronal pharmacology.Assessment of the TRPM8 inhibitor AMTB in breast cancer cells and its identification as an inhibitor of voltage gated sodium channelsA Centipede Toxin Family Defines an Ancient Class of CSαβ DefensinsDevelopment of a high-throughput fluorescent no-wash sodium influx assayAddition of K22 Converts Spider Venom Peptide Pme2a from an Activator to an Inhibitor of NaV1.7.High-Throughput Fluorescence Assays for Ion Channels and GPCRsInflammatory and Neuropathic Gene Expression Signatures of Chemotherapy-Induced Neuropathy Induced by Vincristine, Cisplatin, and Oxaliplatin in C57BL/6J MiceEnzymatic Ligation of a Pore Blocker Toxin and a Gating Modifier Toxin: Creating Double-Knotted Peptides with Improved Sodium Channel NaV1.7 InhibitionNaV 1.6 regulates excitability of mechanosensitive sensory neuronsAntiallodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute postsurgical pain: evidence for analgesic synergy with opioids and baclofen
P50
Q27700858-4EABFA66-347F-4FBA-82E1-76F703F61470Q28596806-4423F91E-223E-4E80-9A69-159E781FA2AFQ30835612-E3DD5E20-0935-4189-94EB-6AD134BB5823Q30839530-F7C555D8-D211-4CD5-A624-7BEE2CD81145Q36310578-2554F28C-C93D-401D-A1A0-9D0359FF74ACQ37107220-3A4B53EE-31F7-4103-8D12-B52C0EC298BEQ38781258-D0AF801F-094C-4713-AEF2-3F7B7EAF14B3Q38913524-FDBC61BB-0AE0-413E-BFAC-FD419B9E237BQ39029029-2E4E8769-2BF2-44F8-AE76-DBBE7C68AA5AQ39137869-7DF9101F-50FC-4B3A-BCD4-29A98409B04BQ39246925-93E3793D-2214-45C2-8C51-9FE000B26C1EQ39320577-84702623-4BD9-44C6-9260-80D6100A066AQ39587472-A8A941E6-61EF-4865-B47C-545275D9ADF1Q40389457-DB606F16-AC52-4625-8798-371A2ED5FCD6Q40993825-5CA6675E-472B-4506-8AFD-10453A04DA6DQ41440352-942F817A-9327-43A6-9DEA-75C1667E5D26Q41576564-50007D28-7F9C-4A48-905E-B38A88294C69Q41852990-E07EBC81-55A8-4606-A4F6-5007BFD493EDQ42156219-00EC5763-04A2-47CA-A9EB-D21DE62DDA64Q44331138-492FAE77-0019-45D2-82C2-8EA479834E85Q46247412-7E52C631-9180-4123-A37A-9D42C8BF9694Q47560412-C8452F8B-D7CA-414E-9B22-BA1F2A01AE87Q47785613-856B8512-CE7E-42DD-BD55-1309C1B2FC7CQ48100659-9B410FC7-AB6A-4E0A-B980-AE7947EAD602Q48149078-5431D7DC-DC6E-40AD-A26A-B193FF8F956FQ50096964-F6942C33-9FB6-4F6C-9F55-EC5CD0360095Q59668917-D2504CC4-4041-4433-B7E7-44FF14FB4400Q61716477-c9e5f04d-425c-d004-195b-02d1f86a804dQ64109296-9F39CD13-3716-46FF-85F4-C83A9666C5C4Q89860164-E4F73F7A-34E6-4623-90E6-E895EEDC8798Q90915816-9FEF99A2-8CC8-4D61-A456-80FCF47BB4B8Q91511655-E2167501-67FF-4C53-9BF4-A18578B1FF8AQ91605515-E43844E1-6CEF-4C6D-8E04-ACD1189177BDQ92007826-1D08FB95-C196-4C8E-BD13-9C21DF591DEEQ92120145-7D4F79FD-5158-4E08-B02E-5956C4C984D7
P50
description
researcher ORCID ID = 0000-0002-5107-8938
@en
wetenschapper
@nl
name
Jennifer Deuis
@ast
Jennifer Deuis
@en
Jennifer Deuis
@es
Jennifer Deuis
@nl
type
label
Jennifer Deuis
@ast
Jennifer Deuis
@en
Jennifer Deuis
@es
Jennifer Deuis
@nl
prefLabel
Jennifer Deuis
@ast
Jennifer Deuis
@en
Jennifer Deuis
@es
Jennifer Deuis
@nl
P21
P31
P496
0000-0002-5107-8938